Spontaneous and inherited TP53 genetic alterations
Open Access
- 13 August 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (41), 5975-5983
- https://doi.org/10.1038/s41388-021-01991-3
Abstract
The p53 protein is a transcription factor that prevents tumors from developing. In spontaneous and inherited cancers there are many different missense mutations in the DNA binding domain of the TP53 gene that contributes to tumor formation. These mutations produce a wide distribution in the transcriptional capabilities of the mutant p53 proteins with over four logs differences in the efficiencies of forming cancers in many diverse tissue types. These inherited and spontaneous TP53 mutations produce proteins that interact with both genetic and epigenetic cellular modifiers of p53 function and their inherited polymorphisms to produce a large number of diverse phenotypes in individual patients. This manuscript reviews these variables and discusses how the combinations of TP53 genetic alterations interact with genetic polymorphisms, epigenetic alterations, and environmental factors to begin predicting and modifying patient outcomes and provide a better understanding for new therapeutic opportunities.Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (PO1 CA087497)
This publication has 71 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Lgr proteins in epithelial stem cell biologyDevelopment, 2013
- A germline variant in the TP53 polyadenylation signal confers cancer susceptibilityNature Genetics, 2011
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor DevelopmentCancer Cell, 2010
- The Origins and Evolution of the p53 Family of GenesCold Spring Harbor Perspectives in Biology, 2009
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathwayNature, 2009
- Epidermal Stem Cells of the SkinAnnual Review of Cell and Developmental Biology, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004